As a UN donors conference for quake-hit Haiti gets under way in New York, AFPTV interviews UNAIDS Executive Director Michel Sidibe on the risks facing the devastated country, which has the highest HIV-AIDS rate in the Caribbean.Duration: 00:45
189347 items (189347 unread) in 47 feeds
World Health Organization
(226 unread)
Media
(146550 unread)
Bird Flu
(3059 unread)
Diabetes
(8426 unread)
Cholesterol
(3564 unread)
Cancer
(15116 unread)
HIV
(7259 unread)
Women
(3814 unread)
Men
(1333 unread)
As a UN donors conference for quake-hit Haiti gets under way in New York, AFPTV interviews UNAIDS Executive Director Michel Sidibe on the risks facing the devastated country, which has the highest HIV-AIDS rate in the Caribbean.Duration: 00:45
Co-infection with human immunodeficiency virus and hepatitis B virus poses a treatment challenge.
There is a major health gap between U.S. minority children and Caucasian children, a review of studies found.
GeoVax Labs, Inc. , a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines , is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine , which is intended as a treatment for individuals infected with HIV .
Canada appears to have pulled the plug on funding to one of the largest AIDS vaccine development agencies in the world, says the Winnipeg Free Press in a report out of Ottawa.